Europe, Middle East & Africa Regional Advisory Council
Max Wegner
-
Vicki Edwards
Vice President, Pharmacovigilance Excellence and QPPV, AbbVie, Inc.
-
Ivana Ferber
Regulatory Affairs Lead Croatia/Bosnia and Herzegovina, Merck Sharp & Dohme
-
Karin M Groendahl
Business Development Manager, MPA (Swedish Medicines Agency)
-
Sabine Haubenreisser
Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency
-
Niklas Hedberg
Chair EUnetHTA Executive Board, Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV
-
Hubert Leufkens
Professor, Pharmaceutical Policy and Regulatory Science, Utrecht University
-
Inger Mollerup
Consultant, Inger Mollerup Regulatory Consulting
-
Mira Pavlovic
HTA Expert / Managing Director, NDA Advisory Services, Medicines Development and Training (MDT) Services
-
Bettina Ryll
Chair ESMO Patient Advocates Working Group (PAWG), Melanoma Patients
-
Claudine Sapède
Director, Global HTA Policy, Novartis Pharma AG
-
Peter Schueler
Senior Vice President, Drug Development Neurosciences, ICON plc (CRO)
-
Phil Tregunno
Group Manager, Vigilance, Intelligence and Research Group, Medicines and Healthcare Products Regulatory Agency (MHRA)
-
Frank Wartenberg
President Central Europe, IQVIA